← All candidates
35 insider filings on record.
Julia LetlowEducation and Workforce · Appropriationstraded 8 Aug 2025 · filed 13 Jan · selfSold$1K–$15Kself8 Aug 20251y ago13 Jan247d agoJulia LetlowEducation and Workforce · Appropriationstraded 14 Apr 2025 · filed 13 Jan · selfBought$1K–$15Kself14 Apr 20251y ago13 Jan247d ago35 filings on record.
CNCCENTENE CORP
NYSE · Healthcare · $32.61B
$66.01
-2.44% · Sep 16
35 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 4 sells◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$32.61B
Float
463.7M
94% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
12.3
Price / sales
0.2
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Executive Officer
London Sarah
Bought $490.4K on Aug 8 — 19,230 sh @ $25.50, held direct, 2.3% of their stake.
1 of 1 position beat the S&P
Director
Samuels Theodore R. II
Bought $248.6K on Jul 28 — 9,000 sh @ $27.62, held indirect, 28% of their stake.
1 of 1 position beat the S&P
Congress
▸ Disclosures lag trades by 30–45 days.
2 disclosures12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
30 more transactions on Pro →Context
Wall St
$71.78 avg target
+8.7% vs today · 18 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q2 '26$2.51 act+$1.43
Q1 '26$3.37 act+$1.24
Q4 '25−$1.19 act+$0.03
Q3 '25$0.50 act+$0.66
The file stays open
35 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice